Seres Therapeutics
MCRB
MCRB
82 hedge funds and large institutions have $232M invested in Seres Therapeutics in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 3.88% → 4.11% (+0.23%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
57% less call options, than puts
Call options by funds: $102K | Put options by funds: $237K
Holders
82
Holding in Top 10
1
Calls
$102K
Puts
$237K
Top Buyers
| 1 | +$8.03M | |
| 2 | +$5.6M | |
| 3 | +$5.5M | |
| 4 |
Millennium Management
New York
|
+$2M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.42M |
Top Sellers
| 1 | -$12M | |
| 2 | -$2.1M | |
| 3 | -$387K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$196K |
| 5 |
D.E. Shaw & Co
New York
|
-$156K |